Mark DeLongVICE PRESIDENT, BUSINESS DEVELOPMENT AND CORPORATE STRATEGY
Mark DeLong joined Apellis in February 2018 and is currently our Vice President, Business Development and Corporate Strategy. Prior to joining Apellis, Mark worked at EMD Serono in Boston, MA from 2007 until January 2018 with various leadership roles in Business Development, Portfolio Management and Commercial Operations. Most recently, Mark served as Head of Portfolio Management for the Neurology and Immunology Global Franchise. Prior to this, Mark was the Head of US Business Development and a member of the US Senior Leadership team, where he was instrumental in multiple strategic partnerships and divestments. Prior to joining EMD Serono, Mark held various R&D positions at Alkermes. Mark holds a BSc in Chemical Engineering from Penn State and an MBA from the University of Michigan.